Automated Manufacture of Matched Donor-Derived Allogeneic CD19 CAR T-Cells for Relapsed/Refractory B-ALL Following Allogeneic Stem Cell Transplantation: Toxicity, Efficacy and the Important Role of Lymphodepletion (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2019-129640

Publication URI: http://dx.doi.org/10.1182/blood-2019-129640

Type: Journal Article/Review

Parent Publication: Blood

Issue: Supplement_1